Evidence map›Paper›PMID 40011796›Full record

ArticleBMC infectious diseases2025

Plasmodium falciparum merozoite surface protein 2 genetic polymorphism and multiplicity of infection in selected malarious areas of Northwest Ethiopia.

Agenagnew Ashagre, Jimma Dinsa Deressa, Daniel Abebe Mekonnen, Melat Abdu, Tegegne Eshetu, Migbaru Keffale, Aberham Abere, Mulugeta Aemero Tegegne

Abstract read
In one paragraph

Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Agenagnew AshagreMedical Laboratory Science, College of Health Science, Woldia University, Woldia, Ethiopia.
Jimma Dinsa DeressaMalaria and NTD Division, Armauer Hansen Research Institute, Ministry of Health, Addis Ababa, Ethiopia.
Daniel Abebe MekonnenMalaria and NTD Division, Armauer Hansen Research Institute, Ministry of Health, Addis Ababa, Ethiopia.
Melat AbduMalaria and NTD Division, Armauer Hansen Research Institute, Ministry of Health, Addis Ababa, Ethiopia.
Tegegne EshetuDepartment of Medical Parasitology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Migbaru KeffaleDepartment of Medical Parasitology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Aberham AbereDepartment of Medical Parasitology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia.
Mulugeta Aemero TegegneDepartment of Medical Parasitology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia. mulugeta.aemero@uog.edu.et.

Funding

University of Gondar VPRCS/515/3/2013
6 · The paper itself

Abstract

backgroundThe genetic diversity of Plasmodium falciparum provides the parasite with many effective immune evasion and drug resistance mechanisms. This phenomenon is a major problem in eradicating malaria globally. This study aimed to assess merozoite surface protein 2 polymorphisms in P. falciparum isolates from Northwest Ethiopia.

methodA cross-sectional study was conducted to assess merozoite surface protein 2 polymorphisms in P. falciparum isolates from selected malarious areas in Northwest Ethiopia from April to June 2021. A convenience sampling technique was used to select 150 study participants. A finger prick blood sample was collected to prepare blood films and dried blood spots for molecular genotyping. The merozoite surface protein 2 allele frequency and multiplicity of infection were computed. Linear regression was employed to evaluate the associations between the multiplicity of infection, parasite density, and age by calculating Spearman's rank correlation coefficients. A P value < 0.05 was considered to indicate statistical significance.

resultPolymorphism analysis was performed on 126 P. falciparum isolates. There were 38 different merozoite surface protein 2 alleles, 20 of which corresponded to the IC/3D7 allelic family and 18 to the FC27 allelic family. Most patients contained multiple infections, and the mean multiplicity of infection was 3.46. There was no statistically significant difference in the multiplicity of infection in relation to the age of patients (P = 0.646). However, a statistically significant correlation was found between parasite density and the multiplicity of infection (P = 0.046). The heterozygosity index for merozoite surface protein 2 was 0.948.

conclusionThis study showed that P. falciparum isolates contain multiple genotypes with a high multiplicity of infections and mixed strain infection, suggesting extensive genetic diversity and a high level of malaria transmission. This genetic variability could complicate malaria treatment and control efforts, as it can facilitate the emergence and spread of drug-resistant strains. Consequently, the findings highlight the complex malaria epidemiology in the region and emphasize the need for intensified efforts to control malaria transmission and prevent the probable emergence of drug resistance alleles in the study area.

Indexed as

Antigens, ProtozoanMalaria, FalciparumPlasmodium falciparumPolymorphism, GeneticProtozoan ProteinsAdolescentAdultAllelesChildChild, PreschoolCross-Sectional StudiesEthiopiaFemaleGene FrequencyGenotypeHumansAntigens, Protozoanmerozoite surface protein 2, PlasmodiumProtozoan ProteinsGenetic diversityGondarMerozoite surface protein 2Northwest EthiopiaPlasmodium falciparumPolymorphism

Identifiers

PMID40011796
PMCPMC11866721

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.